Grantham, Mayo, Van Otterloo & Co (GMO)
OPK icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Opko Health OPK Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,300
Closed -$19K – 811
2020
Q1 		$19K Buy
+14,300
New +$22.4K ﹤0.01% 743

Other funds holding OPK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s OPK Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Opko Health (OPK) in Q2 2020, closing a stake of 14,300 shares — an estimated $19K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OPK in Q1 2020 and held it in 1 quarter. The position peaked at $19K in Q1 2020. 210 funds tracked by Wall St. Rank hold OPK as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Opko Health position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 14,300 Opko Health shares in Q2 2020, an estimated $19K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Opko Health in Q1 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Opko Health position peaked at $19K in Q1 2020.
  • 210 funds tracked by Wall St. Rank held Opko Health as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.